iBio, Inc. — Director's Dealing 2011

May 10, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2011-05-03

Reporting Person: BECK DOUGLAS (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$2.69	2021-05-03	Common Stock (100000)		Direct

Footnotes

F1: The option vests in three equal annual installments, beginning on May 3, 2012.